The pathology of Alzheimer disease (AD) damages structural and functional brain networks,
resulting in cognitive impairment. The results of recent connectomics studies have now …

Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the
Alzheimer's disease (AD) continuum. Investigating populations with SCD is important for …

Alzheimer's disease (AD) is the most common chronic disease in the elderly, with a high
incidence rate. In recent years, deep learning has become popular in the field of medical …

Sensitive and specific antemortem biomarkers of neurodegenerative disease and dementia
are crucial to the pursuit of effective treatments, required both to reliably identify disease and …

Objective To determine the nature and extent of minor neuropsychological deficits in
patients with subjective cognitive decline (SCD) and their association with CSF biomarkers …

Abstract To move Alzheimer Disease (AD) research forward it is essential to collect data
from large cohorts, but also make such data available to the global research community. We …

Background: The early progression continuum of Alzheimer's disease (AD) has been
considered to advance through subjective cognitive decline (SCD), non-amnestic mild …

Early cognitive decline in patients with Alzheimer's (AD) is associated with quantifiable
structural and functional connectivity changes in the brain. AD dysregulation of Aβ and tau …

Alzheimer's disease (AD) is associated with alterations in functional connectivity (FC) of the
brain. The FC underpinnings of CR, that is, lifelong experiences, are largely unknown …

Neuronal dysfunction in specific brain regions or across distributed brain networks is a
known feature of Alzheimer's disease. An often reported finding in the early stage of the …